Ilocos Norte free of Dengvaxia

LAOAG CITY — Ilocos Norte has been spared of the controversial Dengvaxia, the Provincial Health Office (PHO) here assured residents on Tuesday.

Dr. Josephine Ruedas, PHO officer-in-charge, said Ilocos Norte is fortunate to have small number of dengue cases in previous years hence it was least priority as a recipient of the Dengvaxia vaccine distributed by the Department of Health.

She added that they have not monitored any private hospital or medical clinic which administered the vaccine to patients here.

The vaccine was administered to selected public school students in Metro Manila, Central Luzon and Calabarzon. These are the three regions with the highest number of dengue cases.

Under the government’s free dengue vaccination program during the administration of former President Benigno Aquino, the Department of Health reported that more than 800,000 school children were inoculated with Dengvaxia.

Dengvaxia is the world’s first vaccine against dengue virus developed by French pharmaceutical company Sanofi Pasteur.

The dengue vaccine turned controversial after its manufacturer raised health concerns about it. (Leilanie Adriano/PNA)

Popular

PH gets support from Cambodia, Thailand in 2026 ASEAN chairship

By Brian Campued Cambodia and Thailand have conveyed their support for the Philippines’ upcoming chairship of the Association of Southeast Asian Nations (ASEAN) next year. During...

PBBM cites efforts to build ‘future-ready’ PH

By Ruth Abbey Gita-Carlos | Philippine News Agency The Philippines will be “future-ready” through fair taxation, relief for workers and measures to ease the cost...

PBBM champions early childhood education

By Brian Campued President Ferdinand R. Marcos Jr. on Friday distributed 35 school bags and a Starlink unit in La Paz Child Development Center (CDC)...

PBBM welcomes expansion of Bulacan cold storage facility

By Brian Campued President Ferdinand R. Marcos Jr. touted the expansion of the Royale Cold Storage (RCS) facility in Bulacan as a welcome development in...